Precision BioSciences, Inc.
NASDAQ:DTILBiotechnology
+$0.11 today
- Market cap
- $198.34M
- Beta
- 1.28
- P/E (TTM)
- -1.9
- EPS (TTM)
- -$3.47
Volume 0.37M
Average 0.31M
DTIL Total Non-current Assets
All assets not expected to be converted to cash within one year.
Precision BioSciences, Inc.NASDAQ: DTIL
Total Non-current Assets · Q1 FY2026 · quarter ended Mar 2026
Total non-current assets falls 16.8% from a year ago
Total non-current assets stood at $35.2M at the end of Q1 FY2026, down 16.8% from a year earlier and down 1.3% from the prior quarter. Over 3 fiscal years it compounded at -3.0% a year.
Context
- Total non-current assets amounted to 24.5% of total assets at the end of Q1 FY2026, down 9.5 pp from a year earlier.
- Total non-current assets increased in 1 of the last 3 fiscal years.
What to watch
Whether total non-current assets keeps falling in the next quarterly balance sheet after a -16.8% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Total Non-current Assets history
USD · from the balance sheet
- Latest · FY2025
- 35.68M USD
- Year-over-year change
- -13.8%
- 4-year CAGR
- -8.0%
| Period | Period end | Total Non-current Assets | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 35.68M | -13.8% |
| FY2024 | 2024-12-31 | 41.4M | +76.8% |
| FY2023 | 2023-12-31 | 23.42M | -40.0% |
| FY2022 | 2022-12-31 | 39.06M | -21.5% |
| FY2021 | 2021-12-31 | 49.74M | — |
Total Non-current Assets vs competitors
How DTIL compares with its peers on the latest reported figures
- DTIL's Mar 2026 total non-current assets of $35.2M is the highest of the 7 companies compared; the peer median is $6.63M.
- Its year-over-year change of -16.8% is the 2nd highest of 6, against a peer median of -38.0%.
- Total non-current assets amounts to 24.5% of total assets for DTIL, versus a peer median of 5.2%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $35.2M | -16.8% | -3.0% | 24.5% | |
| Mar 2026 | $24.83M | -40.4% | -24.1% | 10.4% | |
| Mar 2026 | $17.23M | -24.8% | -26.9% | 7.0% | |
| Mar 2026 | $6.8M | — | — | 2.3% | |
| Mar 2026 | $6.47M | -38.0% | -23.3% | 10.2% | |
| Mar 2026 | $4.36M | -14.7% | -24.2% | 3.4% | |
| Mar 2026 | $535K | -98.9% | -67.1% | 0.4% | |
| Peer median (excluding DTIL) | $6.63M | -38.0% | -24.2% | 5.2% | |
Competitors are the stored peer set for DTIL. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 143.66M | 189.58M | 116.68M | 85.9M | 110.82M |
| Short-term Investments | 0 | 0 | 0 | 413K | 4.76M |
| Net Receivables | 488K | 720K | 12.8M | 1.7M | 0 |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 169K | 2.78M | 906K | 538K | 45K |
| Total Current Assets | 161.75M | 199.11M | 136.36M | 94.99M | 118.74M |
| Property, Plant & Equipment (Net) | 29.33M | 13.78M | 14.6M | 10.18M | 7.23M |
| Goodwill | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets | 2.05M | 731K | 400K | 622K | 1.17M |
| Long-term Investments | 6.84M | 4.75M | 3.21M | 3.21M | 744K |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 11.52M | 19.81M | 5.22M | 27.39M | 26.54M |
| Total Non-current Assets | 49.74M | 39.06M | 23.42M | 41.4M | 35.68M |
| Total Assets | 211.5M | 238.17M | 159.78M | 136.39M | 154.42M |
| Account Payables | 1.14M | 653K | 2.97M | 1.31M | 296K |
| Short-term Debt | 0 | 0 | 22.41M | 0 | 0 |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 21.24M | 46.19M | 12.04M | 2.96M | 0 |
| Other Current Liabilities | 7.74M | 9.31M | 9.88M | 7.38M | 2.36M |
| Total Current Liabilities | 35.98M | 59.66M | 49.99M | 14.98M | 8.91M |
| Long-term Debt | 2.48M | 22.22M | 0 | 22.32M | 22.4M |
| Deferred Tax Liabilities | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue (Non-current) | 77.02M | 92.87M | 83.08M | 33.3M | 10M |
| Other Non-current Liabilities | 44K | 1.92M | 128K | 2.99M | 15.95M |
| Total Non-current Liabilities | 84.35M | 118.07M | 90.93M | 65.02M | 53.26M |
| Total Liabilities | 120.33M | 177.74M | 140.92M | 80M | 62.17M |
| Common Stock | 0 | 1K | 1K | 1K | 1K |
| Retained Earnings | (316.68M) | (428.31M) | (489.63M) | (482.46M) | (528.19M) |
| Accumulated OCI | 0 | 0 | 0 | 0 | 0 |
| Other Stockholders Equity | 0 | 0 | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 | 0 | 0 |
| Total Equity | 91.17M | 60.43M | 18.86M | 56.39M | 92.25M |
| Total Debt | 9.11M | 24.96M | 31.27M | 30.05M | 28.81M |
| Net Debt | (134.55M) | (164.62M) | (85.41M) | (55.85M) | (82.02M) |
Precision BioSciences, Inc.
NASDAQ:DTIL
Intrinsic Alpha fair value
Locked
Current Price
$7.10
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.